Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trial
© 2020 Elsevier Ltd Background: The RV144 phase 3 vaccine trial in Thailand demonstrated that ALVAC-HIV (vCP1521) and AIDSVAX B/E administration over 6 months resulted in a 31% efficacy in preventing HIV acquisition. In this trial, we assessed the immunological effect of an additional vaccine boost...
Saved in:
Similar Items
-
Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trial
by: Punnee Pitisuttithum, et al.
Published: (2020) -
Evaluating compliance with institutional preoperative testing guidelines for minimal-risk patients undergoing elective surgery
by: Arunotai Siriussawakul, et al.
Published: (2018) -
CONSTRUCTION SAFETY MANAGEMENT FOR ADDITION AND ALTERATION (A&A) PROJECTS
by: ANG KIM KIM
Published: (2012) -
The role of career and wage incentives in labor productivity: Evidence from a two-stage field experiment in Malawi
by: KIM, Hyuncheol, et al.
Published: (2019) -
The selection and causal effects of work incentives on labor productivity: Evidence from a two stage randomized controlled trial in Malawi
by: KIM, Hyuncheol Bryant, et al.
Published: (2017)